[
  {
    "ts": null,
    "headline": "Is CorMedix (CRMD) Stock Outpacing Its Medical Peers This Year?",
    "summary": "Here is how CorMedix (CRMD) and ResMed (RMD) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=c72fc53d3f7e144ca4d32b8373058892888667255e57997f5b3c012d2424faf9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735310411,
      "headline": "Is CorMedix (CRMD) Stock Outpacing Its Medical Peers This Year?",
      "id": 132176762,
      "image": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Here is how CorMedix (CRMD) and ResMed (RMD) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=c72fc53d3f7e144ca4d32b8373058892888667255e57997f5b3c012d2424faf9"
    }
  },
  {
    "ts": null,
    "headline": "Growing Biosimilars Business, New Partnerships Support ABT Stock",
    "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
    "url": "https://finnhub.io/api/news?id=63f4c8306a24657305e688044a6114b4eb366d119cc0fbeda61b6b070c4c8879",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735307160,
      "headline": "Growing Biosimilars Business, New Partnerships Support ABT Stock",
      "id": 132175051,
      "image": "https://media.zenfs.com/en/zacks.com/769ea4b39e167b1ab7916652e1917be6",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
      "url": "https://finnhub.io/api/news?id=63f4c8306a24657305e688044a6114b4eb366d119cc0fbeda61b6b070c4c8879"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now",
    "summary": "Veracyte's progress with key drivers and the strength in its diagnostics tests bring optimism to investors.",
    "url": "https://finnhub.io/api/news?id=2c3016c70bacc688de7b78ea5936b54941bd2f2f179aac6e34d3ebb455ecbc44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735301820,
      "headline": "Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now",
      "id": 132174955,
      "image": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Veracyte's progress with key drivers and the strength in its diagnostics tests bring optimism to investors.",
      "url": "https://finnhub.io/api/news?id=2c3016c70bacc688de7b78ea5936b54941bd2f2f179aac6e34d3ebb455ecbc44"
    }
  }
]